retatrutide phase 2 trial Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished 💉 A triple-action once-weekly injection

Moreover, in terms of reduction in hemoglobin A1c (HbA1c) levels, the 50 mg dose of oral semaglutide outperformed the 14 mg dose, with reductions of 2.1% and 1.3%, respectively, at 68 weeks

Any extra glucose is stored in the liver and muscle tissue until it's needed for more energy

Shot day (and the day after): soft, low-fat, small plates

Kaiser coverage varies by plan, and you may need prior authorization, step therapy, or quantity limits for Mounjaro

Use a permanent marker to write the opened date and discard after date directly on the vial label

That comparison alone should tell you how significant this compound is